Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pancreatic Neoplasms × Diet × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Weight Loss 5 Obesity 5 Breast Neoplasms 5 Polycystic Ovary Syndrome 4 Motor Activity 4 Prostatic Neoplasms 2 Overweight 2 Neoplasms 2 Multiple Endocrine Neoplasia Type 1 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking Cessation 1 Sexual Dysfunction, Physiological 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Menstruation Disturbances 1 Malnutrition 1 Lung Neoplasms 1 Inflammation 1 Infertility 1 Gastrointestinal Neoplasms 1 Diabetes Mellitus, Type 2 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Cancer Female 1 Body Weight Changes 1 Body Weight 1

Interventions

Gemcitabine 328 Fluorouracil 84 Oxaliplatin 70 Capecitabine 66 Albumin-Bound Paclitaxel 64 Radiotherapy 62 130-nm albumin-bound paclitaxel 61 Leucovorin 52 Erlotinib Hydrochloride 46 Irinotecan 45 Cisplatin 43 Bevacizumab 30 Radiosurgery 29 pembrolizumab 25 Docetaxel 25 Taxes 23 Nivolumab 23 Cetuximab 20 Pancreaticoduodenectomy 17 Cyclophosphamide 15 Radiation 13 Drug Therapy 13 folfirinox 12 Endoscopic Ultrasound-Guided Fine Needle Aspiration 12 irinotecan sucrosofate 11 Sorafenib 11 S 1 (combination) 11 Paclitaxel 11 Neoadjuvant Therapy 11 Ipilimumab 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03187028 2021-11-18

PACE

University of Alabama at Birmingham

Phase NA Completed

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡